Cartesian Therapeutics (RNAC) Non-Current Deffered Revenue (2015 - 2023)
Cartesian Therapeutics (RNAC) posted Non-Current Deffered Revenue of $3.54 million for Q4 2023, down 11.1% from the prior quarter.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Non-Current Deffered Revenue (2015 - 2023) Analysis & Trends
Since Q4 2015, Cartesian Therapeutics has reported Non-Current Deffered Revenue for 31 quarters.
- Annual Non-Current Deffered Revenue shows a five-year compound annual growth rate of -23.9% (FY2018 to FY2023).
- In prior years, Cartesian Therapeutics' Non-Current Deffered Revenue was $11.42 million in FY2021 (-70.5%), $38.75 million in FY2020 (+163.9%) and $14.68 million in FY2019 (+6.2%).
- The Q4 2023 figure stands as the lowest quarterly Non-Current Deffered Revenue since Q3 2016.
- The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q3 2020, with growth of 243.5%; the weakest was Q3 2022, with a decline of 72.9%.
- According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $3.98 million (Q3 2023), $4.86 million (Q2 2023) and $5.52 million (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Cartesian Therapeutics | 216.57 Mn | 216.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 3.54 Mn |
| Sep 30, 2023 | 3.98 Mn |
| Jun 30, 2023 | 4.86 Mn |
| Mar 31, 2023 | 5.52 Mn |
| Sep 30, 2022 | 5.44 Mn |
| Jun 30, 2022 | 7.11 Mn |
| Mar 31, 2022 | 10.42 Mn |
| Dec 31, 2021 | 11.42 Mn |
| Sep 30, 2021 | 20.06 Mn |
| Jun 30, 2021 | 24.74 Mn |
| Mar 31, 2021 | 32.30 Mn |
| Dec 31, 2020 | 38.75 Mn |
| Sep 30, 2020 | 51.47 Mn |
| Jun 30, 2020 | 16.41 Mn |
| Mar 31, 2020 | 14.66 Mn |
| Dec 31, 2019 | 14.68 Mn |
| Sep 30, 2019 | 14.98 Mn |
| Jun 30, 2019 | 14.98 Mn |
| Mar 31, 2019 | 13.82 Mn |
| Dec 31, 2018 | 13.82 Mn |
API Access
Cartesian Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();